Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Volt Pharma Associates
Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202
Contact Volt Pharma Associates
Website

 Latest Content from PMHub 

A magic milestone: Sally’s 10-year #LucidLife workiversary

Press Releases | April 19, 2021 | Lucid Group Communications Limited

Our people define our culture and there is no better example of what we are striving to achieve than what Sally Ratcliffe, Scientific Director, Lucid Group, has demonstrated over the...

When Wireless Technology Meets Drug Delivery

Videos and Podcasts | April 15, 2021 | Impetus Digital

Robert Niichel, Founder/CEO of SmartTab, explores the concept of personalized wireless drug delivery, including its advantages, barriers, and current status. We also discuss the future of digital medicine, the Internet...

Effective Leadership During & After the COVID-19 Pandemic

Videos and Podcasts | April 15, 2021 | Impetus Digital

Carol Stiff, Head of Canada at Santen, delves into what effective leadership looks like before, during, and after COVID-19; challenges brought on by the pandemic; the importance of developing partnerships...

InSite Events™ National Pharma Meeting: A Customer Story

White Papers and Resources | April 15, 2021 | Impetus Digital

How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online.

How a design mindset can lead to better medical outcomes

White Papers and Resources | April 14, 2021 | Page & Page Health

By adopting a design philosophy, healthcare companies can develop communications that allow healthcare professionals (HCPs) to better meet the needs of their patients. Imaginatively designed content combined with patient insights...

How does the government plan to reshape the NHS?

White Papers and Resources | April 14, 2021 | Wilmington Healthcare

Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care

Want to give perfect client service? Tough luck, you’re human

White Papers and Resources | April 13, 2021 | Fox&Cat

In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship

WHITE PAPER: Why do men die younger?

White Papers and Resources | April 12, 2021 | IGNIFI

It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...

Shaping the Future of Medicine, Science, and Technology

Videos and Podcasts | April 8, 2021 | Impetus Digital

Dr. José Morey, CEO and Founder of Ad Astra Media, Chief Medical Innovation Officer at Liberty BioSecurity, and the world’s first “intergalactic doctor” discusses AI, space medicine, human augmentation, and...

Virtually, the same: Is it time to rethink congress strategy?

Press Releases | April 8, 2021 | Lucid Group Communications Limited

In this month’s PME, Jonathan Andrew, Technology Director at Lucid Group discusses the digital transformation that swept through the medcomms industry due to the COVID-19 pandemic. In particular, we saw...